Literature DB >> 14604610

Informal payments for health care in transition economies.

Tim Ensor1.   

Abstract

There is considerable evidence that unofficial payments are deeply embedded in the markets for health care in transition countries. Numerous surveys indicate that these payments provide a significant but possibly distorting contribution to health care financing. Unofficial payments can be characterised into three groups: cost contributions, including supplies and salaries, misuse of market position and payments for additional services. There is evidence from across the region on the presence of payment in each category although it is often difficult to distinguish between payment types. Regulatory policy must address a number of issues. Imposing penalties may help to reduce some payments but if the system is simply unable to provide services, such sanctions will drive workers into the private sector. There appears to be some support for formalising payments in order to reduce unofficial charges although the impact must be monitored and the danger is that formal fees add to the burden of payment. Regulation might also attempt to increase the amount of competition, provide information on good performing facilities and develop the legal basis of patient rights. Ultimately, unless governments address the endemic nature of payments across all sectors, policy interventions are unlikely to be fully effective.

Entities:  

Mesh:

Year:  2004        PMID: 14604610     DOI: 10.1016/s0277-9536(03)00007-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  49 in total

1.  Predictors of informal health payments: the example from Turkey.

Authors:  Hacer Ozgen; Bayram Sahin; Paolo Belli; Mehtap Tatar; Peter Berman
Journal:  J Med Syst       Date:  2010-06       Impact factor: 4.460

2.  Informal payments in the Greek health sector amid the financial crisis: old habits die last...

Authors:  Kyriakos Souliotis; Christina Golna; Yannis Tountas; Olga Siskou; Daphne Kaitelidou; Lycourgos Liaropoulos
Journal:  Eur J Health Econ       Date:  2015-02-03

3.  Dealing with ethical problems in the healthcare system in Lithuania: achievements and challenges.

Authors:  V Bankauskaite; I Jakusovaite
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

4.  The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study.

Authors:  Petra Baji; Milena Pavlova; László Gulácsi; Miklós Farkas; Wim Groot
Journal:  Eur J Health Econ       Date:  2013-08-30

Review 5.  Cost-Effectiveness in Global Surgery: Pearls, Pitfalls, and a Checklist.

Authors:  Mark G Shrime; Blake C Alkire; Caris Grimes; Tiffany E Chao; Dan Poenaru; Stéphane Verguet
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

Review 6.  Resource allocation strategies in Southeastern European health policy.

Authors:  Mihajlo B Jakovljevic
Journal:  Eur J Health Econ       Date:  2013-04

7.  A review of literature to understand the complexity of equity, ethics and management for achieving public health goals in India.

Authors:  Pankaj Garg; Jitender Nagpal
Journal:  J Clin Diagn Res       Date:  2014-02-03

8.  When Surgical Resources are Severely Constrained, Who Receives Care? Determinants of Access to Orthopaedic Trauma Surgery in Uganda.

Authors:  Trina Stephens; Alexander Mezei; Nathan N O'Hara; Jeffrey Potter; Rodney Mugarura; Piotr A Blachut; Peter J O'Brien; Tito Beyeza; Gerard P Slobogean
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

Review 9.  Interventions to reduce corruption in the health sector.

Authors:  Rakhal Gaitonde; Andrew D Oxman; Peter O Okebukola; Gabriel Rada
Journal:  Cochrane Database Syst Rev       Date:  2016-08-16

Review 10.  Empirical models of demand for out-patient physician services and their relevance to the assessment of patient payment policies: a critical review of the literature.

Authors:  Olga Skriabikova; Milena Pavlova; Wim Groot
Journal:  Int J Environ Res Public Health       Date:  2010-06-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.